Proteolysis of SARS-associated coronavirus spike glycoprotein

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 235-240

  Simmons, Graham ^a   Rennekamp, Andrew J ^b   Bates, Paul ^b  

^a Blood System Research Institute   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934435809     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_39     Document Type: Conference Paper

References (13)

1. W. Li, M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, and M. Farzan, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature 426, 450-454 (2003).
2. Z. Y. Yang, Y. Huang, L. Ganesh, K. Leung, W. P. Kong, O. Schwartz, K. Subbarao, and G. J. Nabel, pH-Dependent entry of SARS-CoV is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN, J. Virol. 78, 5642-5650 (2004).
3. A. Marzi, T. Gramberg, G. Simmons, P. Moller, A. Rennekamp, M. Krumbiegel, M. Geier, J. Eisemann, N. Turza, B. Saunier, A. Steinkasserer, S. Becker, P. Bates, H. Hofmann, and S. Pohlmann, DC-SIGN and DC-SIGNR interact with Marburg virus and the S protein of SARS-CoV, J. Virol. 78, 12090-12095 (2004).
4. S. Jeffers, S. Tusell, L. Gillim-Ross, E. Hemmila, J. Achenbach, G. Babcock, W. Thomas, Jr., L. Thackray, M. Young, R. Mason, D. Ambrosino, D. Wentworth, J. Demartini, and K. Holmes, CD209L (L-SIGN) is a receptor for SARS-CoV, Proc. Natl. Acad. Sci. USA 101, 15748-15753 (2004).
5. T. Gramberg, H. Hofmann, P. Moller, P. F. Lalor, A. Marzi, M. Geier, M. Krumbiegel, T. Winkler, F. Kirchhoff, D. H. Adams, S. Becker, J. Munch, and S. Pohlmann, LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus, Virology 340, 224-236 (2005).
6. B. J. Bosch, B. E. Martina, R. Van Der Zee, J. Lepault, B. J. Haijema, C. Versluis, A. J. Heck, R. De Groot, A. D. Osterhaus, and P. J. Rottier, Severe acute respiratory syndrome coronavirus infection inhibition using spike protein heptad repeat-derived peptides, Proc. Natl. Acad. Sci. USA 101, 8455-8460 (2004).
7. S. Liu, G. Xiao, Y. Chen, Y. He, J. Niu, C. R. Escalante, H. Xiong, J. Farmar, A. K. Debnath, P. Tien, and S. Jiang, Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-CoV: implications for virus fusogenic mechanism and identification of fusion inhibitors, Lancet 363, 938-947 (2004).
8. B. Tripet, M. W. Howard, M. Jobling, R. K. Holmes, K. V. Holmes, and R. S. Hodges, Structural characterization of the SARS-coronavirus spike S fusion protein core, J. Biol. Chem. 279, 20836-20849 (2004).
9. G. Simmons, J. D. Reeves, A. J. Rennekamp, S. M. Amberg, A. J. Piefer, and P. Bates, Characterization of SARS-CoV spike glycoprotein-mediated viral entry, Proc. Natl. Acad. Sci. USA 101, 4240-4245 (2004).
10. M. Frana, J. Behnke, L. Sturman, and K. Holmes, Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion, J. Virol. 56, 912-920 (1985).
11. C. De Haan, K. Stadler, G. Godeke, B. Bosch, and P. Rottier, Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion, J. Virol. 78, 6048-6054 (2004).
12. H. D. Klenk, R. Rott, M. Orlich, and J. Blodorn, Activation of influenza A viruses by trypsin treatment, Virology 68, 426-439 (1975).
13. G. Simmons, D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates, Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc. Natl. Acad. Sci. USA 102, 11876-11881 (2005).